Review abstract
Nature Immunology 10, 1147 - 1153 (2009)
Published online: 20 October 2009 | doi:10.1038/ni.1799
A coming-of-age story: activation-induced cytidine deaminase turns 10
Rebecca K Delker1, Sebastian D Fugmann2 & F Nina Papavasiliou1
Abstract
The discovery and characterization of activation-induced cytidine deaminase (AID) 10 years ago provided the basis for a mechanistic understanding of secondary antibody diversification and the subsequent generation and maintenance of cellular memory in B lymphocytes, which signified a major advance in the field of B cell immunology. Here we celebrate and review the triumphs in the mission to understand the mechanisms through which AID influences antibody diversification, as well as the implications of AID function on human physiology. We also take time to point out important ongoing controversies and outstanding questions in the field and highlight key experiments and techniques that hold the potential to elucidate the remaining mysteries surrounding this vital protein.
- Laboratory of Lymphocyte Biology, Rockefeller University, New York, New York, USA.
- Laboratory of Cellular and Molecular Biology, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
Correspondence to: F Nina Papavasiliou1 e-mail: papavasiliou@rockefeller.edu.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Antibody diversity: one enzyme to rule them allNature Medicine News and Views (01 Dec 2004)
RNA AIDs DNANature Immunology News and Views (01 May 2003)
See all 9 matches for News And ViewsRESEARCH
Human uracil?DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombinationNature Immunology Article (01 Oct 2003)
53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombinationNature Immunology Article (01 May 2004)
See all 38 matches for Research
